CN101444574B - 一种祖司麻流浸膏的制备及质量检测方法 - Google Patents
一种祖司麻流浸膏的制备及质量检测方法 Download PDFInfo
- Publication number
- CN101444574B CN101444574B CN2008102365620A CN200810236562A CN101444574B CN 101444574 B CN101444574 B CN 101444574B CN 2008102365620 A CN2008102365620 A CN 2008102365620A CN 200810236562 A CN200810236562 A CN 200810236562A CN 101444574 B CN101444574 B CN 101444574B
- Authority
- CN
- China
- Prior art keywords
- daphne giraldii
- fluid extract
- giraldii nitsche
- daphne
- relative density
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001163443 Daphne giraldii Species 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 title claims abstract description 43
- 239000012530 fluid Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 22
- 238000002360 preparation method Methods 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 9
- 239000012085 test solution Substances 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 3
- 206010037660 Pyrexia Diseases 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 230000003760 hair shine Effects 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 abstract description 15
- 238000003908 quality control method Methods 0.000 abstract description 11
- 230000006872 improvement Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 2
- 241000934856 Daphne Species 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000007689 inspection Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 22
- 239000003814 drug Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000011282 treatment Methods 0.000 description 10
- 208000001294 Nociceptive Pain Diseases 0.000 description 9
- 210000004872 soft tissue Anatomy 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 208000026137 Soft tissue injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940025250 camphora Drugs 0.000 description 2
- 239000010238 camphora Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- 206010002027 Amyotrophy Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008037 Arthrogryposis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- HOIXTKAYCMNVMY-PVOAASPHSA-N daphnin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=CC(=O)O2)C2=C1O HOIXTKAYCMNVMY-PVOAASPHSA-N 0.000 description 1
- HOIXTKAYCMNVMY-UHFFFAOYSA-N daphnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=CC(=O)O2)C2=C1O HOIXTKAYCMNVMY-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003715 limbic system Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025005 lumbar spinal stenosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000929 nociceptor Anatomy 0.000 description 1
- 108091008700 nociceptors Proteins 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000000014 opioid analgesic Substances 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000004189 reticular formation Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000005198 spinal stenosis Diseases 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102365620A CN101444574B (zh) | 2008-12-31 | 2008-12-31 | 一种祖司麻流浸膏的制备及质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102365620A CN101444574B (zh) | 2008-12-31 | 2008-12-31 | 一种祖司麻流浸膏的制备及质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101444574A CN101444574A (zh) | 2009-06-03 |
CN101444574B true CN101444574B (zh) | 2011-03-30 |
Family
ID=40740647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102365620A Active CN101444574B (zh) | 2008-12-31 | 2008-12-31 | 一种祖司麻流浸膏的制备及质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101444574B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616054A (zh) * | 2004-09-28 | 2005-05-18 | 张平 | 一种祖师麻冻干粉针剂及其制备方法 |
CN1733147A (zh) * | 2005-09-01 | 2006-02-15 | 赵东科 | 一种治疗软组织疼痛的中药制剂及制备方法 |
-
2008
- 2008-12-31 CN CN2008102365620A patent/CN101444574B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616054A (zh) * | 2004-09-28 | 2005-05-18 | 张平 | 一种祖师麻冻干粉针剂及其制备方法 |
CN1733147A (zh) * | 2005-09-01 | 2006-02-15 | 赵东科 | 一种治疗软组织疼痛的中药制剂及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101444574A (zh) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104784270B (zh) | 一种消肿止痛外用制剂及其制备方法 | |
CN101601796B (zh) | 治疗痹证的中药熏蒸组合物及其引药 | |
CN103735765A (zh) | 一种活络止痛贴及其制备方法 | |
CN103071134B (zh) | 治疗风湿关节疼痛和跌打肿痛的外用制剂及其制备方法 | |
CN101444574B (zh) | 一种祖司麻流浸膏的制备及质量检测方法 | |
CN110755566A (zh) | 一种中药组合物及其制剂和应用 | |
CN108186749A (zh) | 治疗颈椎病的中药组合物及其制备方法 | |
CN1104254C (zh) | 骨伤接骨液 | |
CN102755435B (zh) | 一种治疗皮肤瘙痒的中药制剂及其制备方法 | |
CN114344363A (zh) | 防治肿瘤及相关治疗后手足麻木疼痛的中药组合物 | |
CN108904705A (zh) | 一种治疗绝经后女性慢性痛风性关节炎的中药组合物 | |
CN101239175A (zh) | 舒肺贴及其制备方法 | |
CN104997981A (zh) | 一种治疗局部风湿性疼痛综合症的中药凝胶膏及其制备方法 | |
CN105943700B (zh) | 一种补肾通痹的中药组合物及其制备方法和应用 | |
Hung et al. | Old Technique–New Evidence: topical agents for musculo-skeletal injuries | |
CN1406591A (zh) | 用毛莨科植物制备的抗无菌性炎症的药物及其用途 | |
CN111643606B (zh) | 一种用以治疗失眠的凝胶贴膏及其制备方法 | |
CN109395050A (zh) | 治疗腹泻的儿科外用按摩软膏配方、制备方法和应用 | |
CN1184981C (zh) | 一种止痛擦剂 | |
CN104000688B (zh) | 一种配用磁扣相互作用的止痛贴药 | |
CN103736060B (zh) | 一种腰痛贴及其制备方法 | |
CN1317320A (zh) | 一种治疗风湿痛的外用中成药风湿康透皮治疗液及其制备方法 | |
CN1872165A (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN1238195A (zh) | 一种治疗各种类型精神病的中药——开窍舒神胶囊 | |
CN101474359A (zh) | 一种治疗痛风的苗药贴 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Dongke Maidisen Pharmaceutical Co., Ltd., Yangling Assignor: Zhao Dongke Contract record no.: 2011610000064 Denomination of invention: Method for preparing daphne giraldii fluid extract and controlling the quality of same Granted publication date: 20110330 License type: Exclusive License Open date: 20090603 Record date: 20110630 |
|
ASS | Succession or assignment of patent right |
Owner name: DONGKE MAIDISEN PHARMACEUTICAL CO., LTD., YANGLING Free format text: FORMER OWNER: ZHAO DONGKE Effective date: 20110909 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 712100 XI AN, SHAANXI PROVINCE TO: 710043 XI AN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110909 Address after: 710043 4 floor, Dongxing science and technology building, Xincheng science and Technology Industrial Park, No. 1 Xinke Road, Xi'an Patentee after: Dongke Maidisen Pharmaceutical Co., Ltd., Yangling Address before: 712100 No. 8 Xinqiao Road, Yangling demonstration area, Shaanxi, Xi'an Patentee before: Zhao Dongke |
|
ASS | Succession or assignment of patent right |
Owner name: SHAANXI DONGKE PHARMACEUTICAL LLC Free format text: FORMER OWNER: DONGKE MAIDISEN PHARMACEUTICAL CO., LTD., YANGLING Effective date: 20150216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710043 XI AN, SHAANXI PROVINCE TO: 712100 XIANYANG, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150216 Address after: 712100 No. 8 Xinqiao Road, Yangling demonstration area, Shaanxi Patentee after: SHAANXI DONGKE PHARMACEUTICAL CO., LTD. Address before: 710043 4 floor, Dongxing science and technology building, Xincheng science and Technology Industrial Park, No. 1, Xinke Road, Shaanxi, Xi'an Patentee before: Dongke Maidisen Pharmaceutical Co., Ltd., Yangling |